Characteristics of monoclonal antibody technology

One is specificity, which is highly specific to a specific single epitope. The study of anti-tumor antibody drugs shows that its specificity is mainly manifested in specific binding, selective killing of target cells, targeted distribution in vivo and stronger curative effect.

The second is diversity, which is mainly manifested in the diversity of target antigen and antibody structure and mechanism of action.

Third, it is directional. Antibody drugs can be made directionally, that is, antibody drugs with different therapeutic effects can be prepared according to needs. Based on these characteristics, we can use it to make a "biological missile" to transport drugs, mainly cancer cells, to the lesion, so as to achieve therapeutic effects.